Contemplating the bright future of stem cell therapy for cardiovascular disease

被引：16

作者：

Sánchez P.L. ^{[1
]}

San Román J.A. ^{[2
]}

Villa A. ^{[2
]}

Fernández M.E. ^{[3
]}

Fernández-Avilés F. ^{[4
]}

机构：

[1] Coronary Care Unit, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, 47005 Valladolid

[2] Imaging Unit, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, 47005 Valladolid

[3] Department of Cardiovascular Medicine, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, 47005 Valladolid

[4] Departamento de Fisiología, Instituto de Biología y Genética, Universidad de Valladolid, Valladolid

来源：

Nature Clinical Practice Cardiovascular Medicine | 2006年 / 3卷 / Suppl 1期

关键词：

Cardiovascular repair; Heart Failure; Myocardial infarction; Myocardial regeneration; Stem cell theraphy;

D O I：

10.1038/ncpcardio0456

中图分类号：

学科分类号：

摘要：

Not long ago, it was assumed that mammalian hearts were so differentiated that regeneration of cardiac tissue was not possible, but now an increasing amount of information suggests that the intrinsic regenerative capacity of the heart can be encouraged by stimulating resident stem cells or transplanting extracardiac progenitor cells. In the future, cardiovascular stem cell therapy may be administered to all patients. Here, we review what has happened and look at where we are going. © 2006 Nature Publishing Group.

引用

页码：S138 / S151

页数：13

共 119 条

[1]

Okrainec K., Et al., Coronary artery disease in the developing world, Am Heart J, 148, pp. 7-15, (2004)

[2]

Reddy K.S., Global perspective on cardiovascular disease, Evidence-Based Cardiology, pp. 91-102, (2003)

[3]

Antman E.M., Van de Wert F., Pharmacoinvasive therapy

[4]

the future of treatment for ST elevation myocardial infarction, Circulation, 109, pp. 2480-2486, (2004)

[5]

Eagle K.A., Et al., GRACE Investigators Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: Findings from the Global Registry of Acute Coronary Events (GRACE), Lancet, 359, pp. 373-377, (2002)

[6]

Antman E.M., Et al., ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction), Circulation, 110, pp. 282-292, (2004)

[7]

Pfeffer M.A., Braunwald E., Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications, Circulation, 81, pp. 1161-1172, (1990)

[8]

Bolognese L., Et al., Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction, Circulation, 109, pp. 1121-1126, (2004)

[9]

Beltrami A.P., Et al., Evidence that human cardiac myocytes divide after myocardial infarction, N Engl J Med, 344, pp. 1750-1757, (2001)

[10]

Anversa P., Nadal-Ginard B., Myocyte renewal and ventricular remodelling, Nature, 415, pp. 240-243, (2002)

← 1 2 3 4 5 6 7 8 9 10 →